课题基金 / 基金详情

ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS

ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS
正常和临床人群的眼睛像差
批准号:
6044829
负责人:
RAYMOND A APPLEGATE
金额:
$30.71万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-04-01 至 2004-02-29

项目摘要

项目成果

RAYMOND A APPLEGATE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted From The Applicant's Abstract): In the United States, cataract surgery is the most frequently performed surgical procedure among 30 million Medicare beneficiaries at an estimated cost of $3.5 billion per year. In the Baltimore Eye Survey, cataract is reported as the leading cause of blindness in those over the age of 40, and to be four times more common in African-Americans than in Caucasian-Americans. In the world, cataract is the leading cause of blindness. The proposed research is designed to take a significant step toward reducing blindness resulting from cataract. To evaluate the effectiveness of preventative therapy designed to delay or prevent cataract formation, new sensitive markers of early cataract development and progression need to be identified. This need is specifically recognized and reflected in Objective 1 of the Report of the Lens and Cataract Panel in: Vision Research, A National Plan: 1999-2003. Objective 1 of the NEI report is to: "Determine if there are novel markers that differentiate the normal aging process from the diseased (cataractous) state." To meet objective 1, the Report identifies the need for the development of "morphological and optical markers that can be visualized by noninvasive techniques." The specific aims of the resubmission are to demonstrate that: wavefront sensing can quantify the optical aberrations and local scattering properties of early cataract formation; wavefront sensing can differentiate the normal aging process from the cataractous state; wavefront sensing has the accuracy and precision to be an effective monitoring tool in longitudinal studies of new therapy designed to delay, prevent, or slow cataract formation and progression. These specific aims will be accomplished by modifying Hartmann/Shack wavefront sensor technology to quantify the optical aberrations and local scattering properties of eyes with early cataract and eyes of normals in the 4th, 5th and 6th decades of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optical Aberration and Visual Performance for Highly Aberrated Eyes
  • 批准号:
    9272397
  • 项目类别:
  • 资助金额:
    $37.22万
  • 财政年份:
    2009
  • 负责人:
    RAYMOND A APPLEGATE
  • 依托单位:
Optical aberration and visual performance in highly aberrated eyes
  • 批准号:
    8244513
  • 项目类别:
  • 资助金额:
    $35.64万
  • 财政年份:
    2009
  • 负责人:
    RAYMOND A APPLEGATE
  • 依托单位:
Optical aberration and visual performance in highly aberrated eyes
  • 批准号:
    8039081
  • 项目类别:
  • 资助金额:
    $35.64万
  • 财政年份:
    2009
  • 负责人:
    RAYMOND A APPLEGATE
  • 依托单位:
Optical aberration and visual performance in highly aberrated eyes
  • 批准号:
    7652856
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2009
  • 负责人:
    RAYMOND A APPLEGATE
  • 依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: